Protein-capped iron oxide and cadmium sulfide nanoparticles
|
Synthesize a metallic-based nanoparticle that is effective in preventing
tau aggregation and polymerization to function as a potential AD
treatment
|
Protein-capped iron oxide nanoparticle: 40-50 nm
Cadmium sulfide nanoparticle: 5-20 nm
|
5-100 µg/mL
|
Neuro2a neuroblastoma cell line
|
Both synthesized nanoparticles had optimal biocompatibility with the
Neuro2a neuroblastoma cell line. Additionally, both nanoparticles served
a synergistic effect to prevent tau accumulation and inhibit tau
aggregation
|
116
|